Board Moves to Build on Sustainable Growth

Business Angel Kevin O’Donovan has been announced as Chair of the HEL Board of Directors to help guide the Company, a developer of laboratory tools and process optimisation, to deliver sustainable growth. An experienced investor in the life sciences sector over the last 20 years and a Board member of several companies, Kevin founded the molecular biology instrumentation company, Hybaid, directing its growth from concept to trade sale for £12 million. Kevin has an MBA which he obtained from the UK’s Kingston Business School.

“Through these uncertain times, HEL is continuing to invest in the best talent with the most relevant experience as we scale and grow. I would like to thank Jon for his great support as Interim Chair, at the same time as welcoming Kevin to the team. With significant Board and commercial experience in the scientific sector, Kevin is ideally placed to make sure that the company is taking the right measures to deliver sustainable growth for our investors whilst doing the right things for our employees and our customers,” said Louise Madden, CEO of HEL.

“HEL has a clear vision that through collaboration we can play a significant role in unleashing the potential of the scientific community. We have the ability to solve complex challenges for customers and continue to drive enterprise value. As such, I am very excited to join a great team of skilled scientists and engineers and look forward to driving continued success,” added Kevin O’Donovan.